NASDAQ:PRTO - Proteon Therapeutics, Inc.
$0.40
 $-0.02
-4.45%
4:00PM EDT
2019-05-24
Proteon Therapeutics, Inc. is a late-stage biopharmaceutical company, which focuses on the development of pharmaceuticals to address the needs of patients with renal and vascular disease. The Company is involved in research and development activities. The Company's product candidate, product candidate, vonapanitase, formerly PRT-201, is a recombinant human elastase that it is developing to manage vascular access failure in patients with chronic kidney disease undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The Company has completed Phase II trial of vonapanitase in patients undergoing creation of an arteriovenous fistula (AVF). The Company initiated the first of two Phase III trials, PATENCY-1, for vonapanitase in radiocephalic AVFs. Its vonapanitase product candidate is a recombinant human elastase under development as a treatment to prevent AVF and arteriovenous graft (AVG) patency loss. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  PRTO     avg for
industry  
  avg for
sector  
42 stocks weight:  -0. 26   0. 00   0. 00  
42 stocks rank:  4. 09 K 4. 42 K 4. 42 K
# analyst opinions:  1. 00   2. 00   2. 00  
mean recommendation:  3. 00   2. 50   2. 50  

quick ratio:  4. 97   4. 77   4. 77  
current ratio:  5. 32   4. 86   4. 86  

target price low:  1. 00   14. 94   14. 94  
target price avg:  1. 00   21. 91   21. 91  
target price high:  1. 00   28. 88   28. 88  
1-yr high:  3. 75   22. 10   22. 10  
last close:  0. 40   21. 57   21. 57  
50-day avg:  0. 99   19. 21   19. 21  
200-day avg:  1. 93   15. 43   15. 43  
1-yr low:  0. 36   11. 51   11. 51  
volume:  306. 96 K 7. 22 K 7. 22 K
50-day avg volume:  1. 94 M 11. 60 K 11. 60 K
200-day avg volume:  553. 14 K 9. 48 K 9. 48 K

1-day return:  -4. 45 % 1. 48 % 1. 48 %
this week return:  5. 72 % 8. 64 % 8. 64 %
12-wk return:  -85. 33 % 43. 48 % 43. 48 %
52-wk return:  -82. 81 % 26. 43 % 26. 43 %

enterprise value (EV):  11. 69 M 625. 52 M 625. 58 M
market cap:  7. 66 M 10020. 31 Q 10020. 30 Q
EBITDA:  -21. 39 M 264. 09   4. 25 K
enterprise multiple (EV/EBITDA):  -0. 55   0. 00   0. 00  
total debt:  135. 00 K 687. 38   8. 99 K
debt/equity:  0. 92   0. 55   0. 55  
net income (common):  -21. 18 M 127. 96   2. 24 K

shares outstanding:  19. 59 M 30. 69 M 30. 69 M
shares:  7. 36 M 24. 61 M 24. 61 M
shares short:  1. 01 M 138. 34 K 138. 35 K
shares short prior month:  1. 20 M 144. 84 K 144. 84 K
short ratio:  0. 54   9. 69   9. 69  
short % of float:  9. 38 % 0. 00 % 0. 00 %
total cash/share:  0. 86   0. 00   0. 00  
total cash:  16. 76 M 350. 59   3. 09 K
free cash flow:  -15. 65 M 185. 71   2. 61 K
operating cash flow:  -22. 87 M 240. 38   3. 12 K

book value:  -0. 33   6. 32   6. 32  
price/book:  -1. 20   3. 41   3. 41  
operating margins:  0. 00 % -0. 00 % -0. 00 %
EBITDA margins:  0. 00 % 2157. 19 % 2157. 19 %
profit margins:  0. 00 % 1950. 54 % 1950. 54 %
gross margins:  0. 00 % 92. 77 % 92. 77 %

1-yr max volatility:  -85. 60 % --- ---
1-yr mean volatility:  -0. 05 % 0. 20 % 0. 20 %

1-yr EPS:  -1. 15   3. 00   3. 00  
forward EPS:  -0. 32   -1. 96   -1. 96  
P/E:  -0. 35   7. 18   7. 18  
forward P/E:  -1. 16   -10. 34   -10. 34  
PE/G:  0. 01   9. 74 B 9. 74 B
growth:  -52. 50 % 0. 00 % 0. 00 %
earnings high:  -0. 21   -0. 50   -0. 50  
earnings avg:  -0. 21   -0. 50   -0. 50  
earnings low:  -0. 21   -0. 50   -0. 50  
revenue high:  -0. 00   5. 57 M 5. 58 M
revenue avg:  -0. 00   5. 57 M 5. 58 M
revenue low:  -0. 00   5. 57 M 5. 58 M
return on assets:  -47. 83 % 38. 37 % 38. 37 %
return on equity:  -95. 88 % 72. 45 % 72. 45 %

beta (1yr vs S&P500):  0. 09   1. 22   1. 22  
sharpe (1yr):  -0. 09   0. 84   0. 84  

held % insiders:  7. 00 % 0. 00 % 0. 00 %
held % institutions:  68. 02 % 9. 00 % 9. 00 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-05-24 : PRTO
.       0.63 =          0.63 :: INITIAL WEIGHT
.   + 33.698 =        34.329 :: spline projection addition
.    x 1.281 =        43.984 :: industry recommendation factor
.    x 1.142 =        50.211 :: company recommendation factor
.    x 0.522 =        26.197 :: return on assets factor
.    x 0.041 =          1.08 :: return on equity factor
.    x 2.905 =         3.137 :: current ratio factor
.    x 1.119 =          3.51 :: quick ratio factor
.    x 1.759 =         6.174 :: short ratio factor
.     x 1.15 =         7.102 :: debt-to-equity factor
.    x 2.177 =        15.463 :: P/E factor
.    x 2.209 =        34.157 :: PE/G factor
.    x 1.394 =        47.626 :: beta factor
.     x 0.67 =        31.892 :: sharpe factor
.    x 2.528 =        80.608 :: target low factor
.     x 1.41 =       113.688 :: target mean factor
.    x 1.052 =       119.567 :: target high factor
.    x 1.756 =       209.962 :: industry 2-weeks return factor
.    x 0.836 =       175.544 :: "drift" penalty 1 days ago
.     x 0.89 =       156.164 :: "drift" penalty 2 days ago
.    x 0.521 =        81.327 :: "drift" penalty 3 days ago
.    x 0.637 =        51.812 :: "drift" penalty 4 days ago
.    x 0.925 =        47.942 :: "drift" penalty 5 days ago
.    / 6.521 =         7.352 :: overall "drift" factor
.    x 0.996 =         7.324 :: largest single-day jump factor
.     x 0.06 =         0.436 :: low price factor
.    x 1.001 =         0.437 :: factor hist industry gain for week 20
.    - 0.701 =        -0.264 :: add/subtract for investor sentiment
.                     -0.264 :: FINAL WEIGHT for NASDAQ:PRTO


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org